Roche Drugs, Chemo Destroy 46 Percent of Breast Tumors

Combining experimental antibody drug pertuzumab with Herceptin, an antibody first approved in 1998, and chemotherapy shrank tumors in nearly half of newly diagnosed breast cancer patients treated in a clinical trial.
CNBC